These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17095870)

  • 1. The role of induced sputum in amiodarone-associated interstitial lung diseases.
    Fireman E; Topilsky I; Viskin S; Priel IE
    Cardiology; 2007; 108(4):223-7. PubMed ID: 17095870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
    Tanawuttiwat T; Harindhanavudhi T; Hanif S; Sahloul MZ
    Heart Lung Circ; 2010 Jul; 19(7):435-7. PubMed ID: 20356785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial pneumonitis in a patient treated with amiodarone -- case report].
    Paczek A; Szturmowicz M; Wiatr E; Burakowska B; Fijałkowska A; Torbicki A
    Pneumonol Alergol Pol; 2008; 76(2):118-24. PubMed ID: 18464227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings.
    Omeroglu G; Kalugina Y; Ersahin C; Wojcik EM
    Diagn Cytopathol; 2006 May; 34(5):351-4. PubMed ID: 16604561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical lessons from an elderly man with amiodarone-induced interstitial lung disease.
    Rayner B
    S Afr Med J; 2007 May; 97(5):360, 362. PubMed ID: 17599218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug-induced pulmonary interstitial disease].
    Freise J; Wehmeier P; Welte T
    Dtsch Med Wochenschr; 2010 Mar; 135(10):450-4. PubMed ID: 20198541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids.
    Chatterjee K; Rochlani YM; Kuriakose K; AndrewDunn ; Khasawneh K; Paydak H
    J Ark Med Soc; 2017 Jun; 113(12):294-296. PubMed ID: 29649357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone.
    Jackevicius CA; Tom A; Essebag V; Eisenberg MJ; Rahme E; Tu JV; Humphries K; Behlouli H; Pilote L
    Am J Cardiol; 2011 Sep; 108(5):705-10. PubMed ID: 21704281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amiodarone pulmonary toxicity: radiological coexistence of nodules with interstitial and alveolar abnormalities].
    de Granda Orive JI; Herrera de la Rosa A; Martínez Albiach JM; Escobar Sacristán JA; Sáez Valls R; Gallego Rodríguez V
    An Med Interna; 1998 May; 15(5):267-9. PubMed ID: 9629776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure.
    Kumar S; Bangalore S; Kumari R; Grosu H; Jean R
    J Emerg Med; 2012 Nov; 43(5):e311-4. PubMed ID: 21459542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRCT findings of amiodarone pulmonary toxicity: clinical and radiologic regression.
    Poll LW; May P; Koch JA; Hetzel G; Heering P; Mödder U
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):307-11. PubMed ID: 11584337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone-induced pulmonary toxicity in an adolescent.
    Kothari SS; Balijepally S; Taneja K
    Cardiol Young; 1999 Mar; 9(2):194-6. PubMed ID: 10323520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia.
    Cappannoli L; Telesca A; Scacciavillani R; Petrolati E; Smargiassi A; Rabini A; Massetti M; Crea F; Aspromonte N
    Future Cardiol; 2021 Sep; 17(6):991-997. PubMed ID: 33331164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bronchiolitis obliterans with organizing pneumonia in a patient treated with amiodarone].
    Boras Z; Krizanac S; Rakusić N
    Lijec Vjesn; 2003; 125(5-6):131-4. PubMed ID: 14533463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced sputum in interstitial lung diseases.
    Fireman E; Lerman Y
    Curr Opin Pulm Med; 2006 Sep; 12(5):318-22. PubMed ID: 16926645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity.
    Endoh Y; Hanai R; Uto K; Uno M; Nagashima H; Narimatsu A; Takizawa T; Onishi S; Kasanuki H
    Am J Cardiol; 2000 Jul; 86(2):229-31. PubMed ID: 10913491
    [No Abstract]   [Full Text] [Related]  

  • 17. KL-6 as a serum marker for amiodarone-induced pulmonary toxicity.
    Kohno N; Yokoyama A; Kondo K
    Intern Med; 2000 Dec; 39(12):1004-5. PubMed ID: 11197780
    [No Abstract]   [Full Text] [Related]  

  • 18. [Spontaneous remission of an amiodarone-induced pulmonary lesion].
    Müller M; Schima W; Weissel M
    Wien Klin Wochenschr; 1997 Nov; 109(22):887-9. PubMed ID: 9476338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interstitial pneumopathy 2 months after discontinuing treatment with amiodarone].
    Wilhelm JM; Thannberger P; Derragui A; Ruxer S; Saraceni O; Kieffer P
    Presse Med; 1999 Nov; 28(37):2040. PubMed ID: 10605474
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
    Ulrik CS; Aldershvile J
    Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.